静脉血栓栓塞是心肌梗死和脑卒中后最常发生的急性心血管并发症之一，其中肺栓塞又是致残和致死率最高的临床表现形式。因此，一旦确诊肺栓塞，即应进行积极干预，目前常用的治疗手段包括抗凝、溶栓、介入和外科手术。近年来，肺栓塞危险分层策略的演变，新型口服抗凝药的出现，溶栓适应证的改变等为肺栓塞的治疗带来了革命性的发展。现就肺栓塞治疗的最新研究进展进行简要综述。“,”Venous thromboembolism is one of the most frequent acute cardiovascular complication.Its most serious clinical presenta-tion, acute pulmonary embolism, is a major cause of mortality and morbidity.Therefore, upon the diagnosis of pulmonary embolism, active treatments such as anticoagulation, thrombolysis, interventional or surgical operation, should be considered.Recently, the evolution of risk stratification strategies, the emergence of new oral anticoagulants, and changes in thrombolysis indications, have created a new therapy for pulmonary embolisms.Here, we briefly review the recent advances in the management of pulmonary embolisms.